| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 11.36 Billion | USD 19.03 Billion | 5.3% | 2024 |
FrequentlyAsked Questions
Medical practitioners and healthcare service providers utilize deflectable catheters across the globe due to their massive utilization as therapeutic devices and drug delivery devices. These products comprise a long catheter body with an electrode positioned along the distal portion of the body of the catheter. The device helps in the navigation of blood across the heart tissues and blood vessels under extreme stress. Escalating demand for minimally invasive surgeries of heart or heart valves along with the need for accessing various anatomical body parts in humans for the purpose of biopsy has increased the demand for deflectable catheters.
The global deflectable catheters market is expected to grow due to advancements in minimally invasive surgeries and increasing prevalence of cardiac and neurological disorders.
According to a study, the global deflectable catheters market size was worth around USD 11.36 Billion in 2024 and is expected to reach USD 19.03 Billion by 2034.
The global deflectable catheters market is expected to grow at a CAGR of 5.3% during the forecast period.
North America is expected to dominate the deflectable catheters market over the forecast period.
Leading players in the global deflectable catheters market include MAC Medical Inc., Medical Murray, Biosense Webster (Johnson & Johnson), Abbott Laboratories Inc., Spectrum Plastics Group, Boston Scientific Corporation, J&J MedTech, CathRx Ltd., Medtronic Plc., Teleflex Incorporated, Biomerics, Duke Extrusion, Merit Medical Systems Inc., Dynaflex, Integer Holdings, Gemini MedTech, and BioCardia Inc., among others.
The report explores crucial aspects of the deflectable catheters market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients